CD8A and neoplasm: There is a correlation between intraepithelial CD8+ T cell infiltration and pathological response to neoadjuvant atezolizumab treatment in MIBC; however, no significant correlation between PD-L1 expression on either immune cells or tumour cells and outcome after neoadjuvant atezolizumab treatment was found [31].